J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.D300021-JLR200 on July 16, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
D300021-JLR200v1
44/10/2006    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kujiraoka, T.
Right arrow Articles by Hattori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kujiraoka, T.
Right arrow Articles by Hattori, H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 44, 2006-2014, October 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology

Methods

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus

Takeshi Kujiraoka*, Tadao Iwasaki*, Mitsuaki Ishihara*, Mayumi Ito*, Makoto Nagano*, Akito Kawaguchi{dagger}, Sadao Takahashi§, Jun Ishi**, Masahiro Tsuji{dagger}{dagger}, Tohru Egashira*, Irina P. Stepanova§§, Norman E. Miller§§ and Hiroaki Hattori1,*

* Department of Advanced Medical Technology and Development, BML, Inc., Saitama, Japan
{dagger} Graduate School of Education, Hokkaido University, Sapporo, Japan
§ Third Department of Internal Medicine, Fukui Medical University, Fukui, Japan
** Division of Internal Medicine, Hokkaido Hospital for Social Health Insurance, Sapporo, Japan
{dagger}{dagger} Institute of Medical Science, Health Sciences University of Hokkaido, Sapporo, Japan
§§ Molecular Pathology Laboratory, International Center for Genetic Engineering and Biotechnology, Trieste, Italy

1 To whom correspondence should be addressed. e-mail: hhiro{at}bml.co.jp

Platelet-activating factor acetylhydrolase (PAF-AH) is a phospholipase A2 associated with lipoproteins that hydrolyzes platelet-activating factor (PAF) and oxidized phospholipids. We have developed an ELISA for PAF-AH that is more sensitive than previous methods, and have quantified HDL-associated and non-HDL-associated PAF-AH in healthy, hyperlipidemic, and diabetic subjects. In healthy subjects, plasma total PAF-AH concentration was positively correlated with PAF-AH activity and with plasma total cholesterol, triacylglycerol, LDL cholesterol and apolipoprotein B (apoB) concentrations (all P < 0.01). HDL-associated PAF-AH concentration was correlated positively with plasma apoA-I and HDL cholesterol. Subjects with hyperlipidemia (n = 73) and diabetes mellitus (n = 87) had higher HDL-associated PAF-AH concentrations than did controls (P < 0.01). Non-HDL-associated PAF-AH concentration was lower in diabetic subjects than in controls (P < 0.01). Both hyperlipidemic and diabetic subjects had lower ratios of PAF-AH to apoB (P < 0.01) and higher ratios of PAF-AH to apoA-I (P < 0.01) than did controls.

Our results show that the distribution of PAF-AH mass between HDLs and LDLs is determined partly by the concentrations of the lipoproteins and partly by the mass of enzyme per lipoprotein particle, which is disturbed in hyperlipidemia and diabetes mellitus.

Abbreviations: CHO, Chinese hamster ovary; MAb, monoclonal antibody; PAF-AH, platelet-activating factor acetylhydrolase

Supplementary key words platelet-activating factor acetylhydrolase • high density lipoprotein • low density lipoprotein • lipoprotein-associated phospholipase A2 • ELISA • Invader® assay


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. A. Gardner, E. C. Reichert, M. K. Topham, and D. M. Stafforini
Identification of a Domain That Mediates Association of Platelet-activating Factor Acetylhydrolase with High Density Lipoprotein
J. Biol. Chem., June 20, 2008; 283(25): 17099 - 17106.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Okada, M. Miyashita, Y. Kuromori, F. Iwata, K. Harada, and H. Hattori
Platelet-activating factor acetylhydrolase concentration in children with abdominal obesity.
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): e40 - e41.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Ishihara, T. Kujiraoka, T. Iwasaki, M. Nagano, M. Takano, J. Ishii, M. Tsuji, H. Ide, I. P. Miller, N. E. Miller, et al.
A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration
J. Lipid Res., September 1, 2005; 46(9): 2015 - 2022.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.